Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose: The aim of this prospective study was to evaluate quality of life (QoL) and sexual function of women affected by endometriosis pain treated with Dienogest (DNG) for 24 months. Patients and methods: Fifty-four women constituted the study group and were given DNG 2 mg/daily; 38 women were given non-steroidal anti-inflammatory drugs (NSAIDs) and constituted the control group. To define endometriosis-associated pelvic pain, dysmenorrhea and dyspareunia the Visual Analogic Scale (VAS) was used. The Short Form-36 (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess the QoL, sexual function and the sexual distress, respectively. The study included five follow-ups at 3, 6, 12, 18 and 24 months. Results: Slight improvements in chronic pelvic pain, dysmenorrhea and dyspareunia were observed in the study group at 3 months ( p <0.05) and improved more from 6 to 24 months of DNG treatment ( p <0.001). QoL improved with a similar trend: at 3 months the improvement was significant in several categories ( p <0.05), and from 6 to 24 months in all categories ( p <0.001). The FSFI score did not change at the 3 month follow-up ( p =not significant [NS]) but it improved from 6 to 24 months ( p <0.001). A similar trend was observed for the FSDS score ( p <0.001). No change was observed in the control group ( p =NS). Conclusion: Long-term treatment with DNG 2 mg once-daily in women with endometriosis-associated pelvic pain may have positive effects on the QoL and sexual life, confirming the observations of the previous study on the first 6 months of treatment. Keywords: dyspareunia, endometriosis, chronic pelvic pain, long term dienogest, quality of life, sexual life
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Patients treated with DNG have also shown an improvement of sexual functioning [194] and QoL [187, 199].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [199]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211 · cited 1×
“The current study has some limitations: endometriosis was not confirmed by laparoscopic exploration and biopsy also because the goal was to investigate about medical therapy and it’s not encouraged by the guidelines to perform laparoscopy without treating the lesions during the same surgery.(2) The lack of randomizati…”
BackgroundEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 1×
“31,32 The multidisciplinary nature of chronic pelvic pain may cause confusion for a correct diagnosis and treat-ment.”
Gallagher, E. J., Liebman, M., & Bijur, P. E. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.118863 · Cited by 1,024
Derogatis, L. R., Rosen, R., Leiblum, S., Burnett, A., & Heiman, J. (2002) · Journal of Sex & Marital Therapy · doi:10.1080/00926230290001448 · Cited by 791
The Factor Structure of the SF-36 Health Survey in 10 Countries
Ware, J. E., Kosinski, M., Gandek, B., Aaronson, N. K., Apolone, G., Bech, P., Brazier, J., Bullinger, M., Kaasa, S., Leplège, A., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00107-3 · Cited by 655
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751.pub3 · Cited by 562 · cited 1×
“Several women take on-demand non-steroidal anti-inflammatory drugs (NSAIDs) as first line agents to control their pelvic pain.(14) Hormonal treatment is adopted only after a specialist diagnoses endometriosis as the cause of the pelvic pain.”
BackgroundAnxiety and depression in patients with endometriosis: impact and management challenges
Laganà, A. S., La Rosa, V. L., Rapisarda, A. M. C., Valenti, G., Sapia, F., Chiofalo, B., Rossetti, D., Ban Frangež, H., Vrtačnik Bokal, E., & Giovanni Vitale, S. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s119729 · Cited by 405
Self-citationTreatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397 · cited 1×
“33 The delay of an appropriate treatment negatively affects the QoL of woman, often not restricting the progression of endometriosis.”
Priorities for Endometriosis Research: Recommendations From an International Consensus Workshop
Rogers, P. A. W., D’Hooghe, T. M., Fazleabas, A., Gargett, C. E., Giudice, L. C., Montgomery, G. W., Rombauts, L., Salamonsen, L. A., & Zondervan, K. T. (2009) · Reproductive Sciences · doi:10.1177/1933719108330568 · Cited by 346 · cited 1×
“Introduction Endometriosis-associated pelvic pain affects approximately 10% of women of reproductive age.(1)”
Cited by
Della Corte, L., Di Filippo, C., Gabrielli, O., Reppuccia, S., La Rosa, V. L., Ragusa, R., Fichera, M., Commodari, E., Bifulco, G., & Giampaolino, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134683 · Cited by 387
“Even medical therapy, in particular progestin, can improve the symptoms of patients [20].”
BackgroundHormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Use of dienogest in endometriosis: a narrative literature review and expert commentary
Murji, A., Biberoğlu, K., Leng, J., Mueller, M. D., Römer, T., Vignali, M., & Yarmolinskaya, M. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1744120 · Cited by 116
Gender Differences and Quality of Life in Parkinson’s Disease
Crispino, P., Gino, M., Barbagelata, E., Ciarambino, T., Politi, C., Ambrosino, I., Ragusa, R., Marranzano, M., Biondi, A., & Vacante, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010198 · Cited by 100
Quality of Life in Women with Deep Endometriosis: A Cross-Sectional Study
Yela, D. A., Quagliato, I. D. P., & Benetti-Pinto, C. L. (2020) · Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics · doi:10.1055/s-0040-1708091 · Cited by 54
As‐Sanie, S., Laufer, M. R., Missmer, S. A., Murji, A., Vincent, K., Eichner, S. F., Cross, S. J., Soliman, A. M., & Tu, F. F. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1929896 · Cited by 47
Patient-Reported Outcome Measures in Endometriosis
Nicolás‐Boluda, A., Oppenheimer, A., Bouaziz, J., & Fauconnier, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215106 · Cited by 48
Mehdizadehkashi, A., Niakan, G., Ebrahimpour, M., Allahqoli, L., Hassanlouei, B., Gitas, G., & Alkatout, İ. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13677 · Cited by 52
Endometriosis-associated pain: a review of quality of life, sexual health and couple relationship
ROSSI, V., Tripodi, F. M., Simonelli, C., Galizia, R., & Nimbi, F. M. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04781-3 · Cited by 43
Sexual function in patients with endometriosis: a prospective case–control study in China
Yang, X., Xu, X., Lin, L., Xu, K., Xu, M., Ye, J., & Shen, X. (2021) · Journal of International Medical Research · doi:10.1177/03000605211004388 · Cited by 37
“However, sexuality is an important component of health-related quality of life because progressive reduction in pain reported by women over the treatment period could have contributed to improving their quality of life and their sexual life.(28) This may have caused bias and affected the outcome.”
BackgroundHormonal Treatment of Endometriosis: A Narrative Review
Piriyev, E., Schiermeier, S., & Römer, T. (2025) · Pharmaceuticals · doi:10.3390/ph18040588 · Cited by 34
“Improvements in quality of life and sexual well-being can be expected from the long-term use of dienogest [44].”
Quality of Life in Liver Transplant Recipients: A Retrospective Study
Girgenti, R., Tropea, A., Buttafarro, M. A., Ragusa, R., & Ammirata, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113809 · Cited by 34
“Bravata, Olkin, Barnato, Keeffe, Owens (1999) [12] Health-related quality of life after liver transplantation: a meta analysis Meta-analysis N/A N/A Transplant recipients reported large gains in those aspects of QOL most affected by physical health and smaller improvements in areas affected by psychological functionin…”
BackgroundA systematic review on the effects of endometriosis on sexuality and couple's relationship.
Norinho, P., Martins, M. V., & Ferreira, H. (2020) · PubMed · Cited by 62
Caruso, S., Cianci, A., Iraci, M., Panella, M. M., Caruso, G., & Cianci, S. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01737-7 · Cited by 40
“In fact, although DNG has antiandrogenic activity that could reduce sexual desire and arousal, the decrease in painful symptoms, especially dyspareunia, may be capable of promoting satisfactory sexual function [19].”
BackgroundSelf-citationNiakan, G., Rokhgireh, S., Ebrahimpour, M., & Mehdizadehkashi, A. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.96 · Cited by 23
The Need of Personalized Medicine in Coping with Stress during Infertility Treatment
Nagórska, M., Obrzut, B., Ulman, D., & Darmochwał-Kolarz, D. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010056 · Cited by 23
“It has been proven many times that infertility causes many psychological problems [32], increases the level of stress [18,29,33], and can also lead to depression [23,32].”
BackgroundWu, H., Liu, J.-J., Ye, S.-T., Liu, J., & Li, N. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.03.032 · Cited by 20
Alcalde, A. M., Martínez-Zamora, M. Á., Gràcia, M., Ros, C., Rius, M., & Carmona, F. (2021) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2021.1986444 · Cited by 20
“Several studies have reported impairment in sexual function in patients with endometriosis (Caruso et al., 2019; Evangelista et al., 2014); however, to our knowledge, few studies have evaluated sexual quality of life in patients with AD (Andersson et al.”
BackgroundCaruso, S., Cianci, A., Iraci, M., Fava, V., Pasqua, S. D., & Cianci, S. (2020) · Journal of Women s Health · doi:10.1089/jwh.2020.8291 · Cited by 22
Self-citationThe challenge of endometriosis for female sexual health
Vannuccini, S., Maseroli, E., Vignozzi, L., & Petraglia, F. (2023) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdad004 · Cited by 19
“Previous studies suggested that dienogest decreased the intensity of deep dyspareunia among women with DIE, 62 the compound was effective for long-term treatment, 63 and enhanced sexual function, albeit without restoring levels to normal.”
BackgroundUpdate on the management of endometriosis-associated pain in France
Fernandez, H., Agostini, A., Baffet, H., Chabbert‐Buffet, N., Descamps, P., Estrade, J.-P., Giraudet, G., Hocké, C., Salle, B., Trémollières, F., et al. (2023) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2023.102664 · Cited by 19
Maiorana, A., Alfano, P., Mercurio, A., Marcantonio, S., Minneci, G., Incandela, D., & Audino, P. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-06942-9 · Cited by 24
“It is know that patients are willing to accept the spotting that DNG can cause given the pain relief experienced [17] and may also have positive effects on their QoL and sexual life [18].”
BackgroundMiao, J., Lu, J., Tang, J., & Lu, P. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2098948 · Cited by 18
Cianci, S., Perrone, E., Rossitto, C., Fanfani, F., Tropea, A., Biondi, A., Scambia, G., & Alletti, S. G. (2020) · Updates in Surgery · doi:10.1007/s13304-020-00893-5 · Cited by 17
Self-citationAssessment of quality of sexual life in women with adenomyosis
Alcalde, A. M., Martínez‐Zamora, M. Á., Gràcia, M., Ros, C., Rius, M., & Carmona, F. (2021) · Women & Health · doi:10.1080/03630242.2021.1920557 · Cited by 18
“…of life, it will presumably also negatively affect the global quality of life, taking into account that sexuality is an important component of healthrelated quality of life, as shown in studies conducted in patients with endometriosis (Caruso et al. 2020; Caruso et al. 2019; Marinho et al. 2018).”
BackgroundMethodInfluentialSexual function and quality of life in women with endometriosis
TROÌA, L., & Luisi, S. V. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05033-3 · Cited by 16
Morgante, G., Cappelli, V., Troìa, L., & Leo, V. D. (2020) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2020.1736546 · Cited by 16
“The contraceptive efficacy of the EE/DNG combination is due to numerous mechanisms, in particular the action of DNG at its effective dose of 2mg [30].”
BackgroundMercorio, A., Corte, L. D., Dell’Aquila, M., Pacella, D., Bifulco, G., & Giampaolino, P. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15975 · Cited by 13
“Although some studies have identified impairments in sexual function among endometriosis patients, 14,15 particularly in those with DIE, 16,17 research specifically addressing sexual dysfunction in patients with adenomyosis, either as an isolated condition or in combination with rectovaginal septum…”
Turco, L. C., Vizzielli, G., Vargiu, V., Alletti, S. G., Ninno, M. D., Ferrandina, G., Anchora, L. P., Scambia, G., & Cosentino, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737938 · Cited by 13
Progesterone receptor ligands for the treatment of endometriosis
Clemenza, S., Capezzuoli, T., Eren, E., GARCIA, J. M. G., Vannuccini, S., & Petraglia, F. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05157-0 · Cited by 13
Porto, B. T. D. C., Ribeiro, P. A., Kuteken, F. S., Ohara, F., & Ribeiro, H. S. A. A. (2024) · Women & Health · doi:10.1080/03630242.2024.2382418 · Cited by 12
“QoL, measured using the EHP30 questionnaire, in accordance with our research, had improvements in some categories at 3 months and across all categories between 6 and 24 months of treatment (Caruso et al. 2019).”
Mariani, L. L., Novara, L., Mancarella, M., Fuso, L., Casula, E., & Biglia, N. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1903420 · Cited by 12
“At the moment, dienogest is the most important progestin used for the treatment of endometriomas, allowing in several cases a reduction in the size of the cysts [22,23] and benefits in terms of quality of life and sexual function even in the setting of long-term treatment, with fairly good tolerability [24,25].”
The effect of dydrogesterone on sexual function in endometriosis
Bahat, P. Y., Yücel, B., Yüksel, B., Kadiroğullari, P., Selçuki, N. F. T., Cakmak, K. B., & Özdemir, E. Ü. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.1958765 · Cited by 14
“In a prospective study (Caruso et al. 2019) discussed the effect of dyspareunia on woman’s sexual desire and reported that pain during sexual intercourse has adverse effects on coital frequency, desire, arousal and experience of orgasm.”
BackgroundInfluentialInduction and characterization of a rat model of endometriosis
Chauhan, J. K., Dubey, P. K., Rai, S., & Tripathi, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-69440-1 · Cited by 13
Caruso, S., Cianci, S., Caruso, G., Iraci, M., Gulino, F. A., & Palumbo, M. A. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.11.015 · Cited by 13
Self-citationRNA sequencing‐based long non‐coding RNA analysis and immunoassay in ovarian endometriosis
Bi, J., Wang, D., Cui, L., & Yang, Q. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13359 · Cited by 11
Factors affecting self-esteem and disease acceptance in patients from infertile couples
Nagórska, M., Zych, B., Obrzut, B., & Darmochwał-Kolarz, D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1177340 · Cited by 10
He, G., Chen, J., Peng, Z., Feng, K., Luo, C., & Zeng, X. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.830698 · Cited by 9
Del Forno, S., Orsini, B., Verrelli, L., Caroli, M., Aru, A. C., Lenzi, J., Raimondo, D., Arena, A., Borghese, G., Paradisi, R., et al. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07125-2 · Cited by 8
Non-invasive diagnosis and non-surgical treatment of endometriosis: A review
Podzolkova, N. M., Fadeev, I. E., Евгеньевна, М. Е., Poletova, T. N., Вячеславовна, С. Л., & Denisova, T. V. (2022) · GYNECOLOGY · doi:10.26442/20795696.2022.3.201508 · Cited by 8
“В обсервационных исследованиях в дозе 2 мг в сутки препарат существенно снижал тазовую боль и повышал качество жизни соразмерно с постоянным приемом агонистов ГнРГ, существенно превосходя НПВС и плацебо по выраженности эффекта, а агонисты ГнРГ – по переносимости длительной (1–2 года) терапии [27].”
Lin, S., Wang, X., Fu, X.-L., Yang, W., Wu, H., Bai, Y., Shi, Z.-N., Du, J., & Wang, B.-J. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i4.377 · Cited by 6
Estrogen and progesterone receptors in endometriosis
Ferreira, L. R. G., Cavalcanti, T. C. S., Zomer, M. T., Kondo, W., Júnior, E. A., & Kulak, J. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04888-0 · Cited by 7
Progestins and combined oral contraceptives in the hormonal treatment of endometriosis – a review
Rojek, K. (2023) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2023.2.21 · Cited by 6
Biasioli, A., Zermano, S., Previtera, F., Arcieri, M., Martina, M. D., Raimondo, D., Raffone, A., Restaino, S., Vizzielli, G., & Driul, L. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121646 · Cited by 7
“…that all hormonal medical treatments lead to a clinically signi fi cant reduction in pain [26,28]. difference was found in the SF-36 score level [29–31], nor when considering the individual items of this questionnaire (Physical Activity, Role However, according to our data, no statistically signi…”
BackgroundGuideline No. 468: Clinical Management of Endometriosis
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103382 · Cited by 5
Advances in the medical treatment of adolescent endometriosis
Yang, L., Yu, J., Zhang, S., & Zhang, J. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.21.06375-8 · Cited by 5
The clinical effect of dienogest on urinary and sexual symptoms in endometriosis patients
Long, C., Chang, C.-T., Lin, K., Yeh, C.-L., Feng, C., & Loo, Z.-X. (2024) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001154 · Cited by 4
“Caruso et al 33 showed that with long-term use of DNG for 2 years, the FSFI scores did not change at the 3-month follow-up but improved from 6 to 24 months, with FSDS scores also showing a similar trend.”
Park, Y., Bae, N., Choo, S. P., Lee, I., Lee, J. H., Kim, Y. J., Cho, S., Choi, Y. S., & Shin, J. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114540 · Cited by 3
Endometrioma: a new paradigm of diagnostics and therapeutic tactics
Gasparyan, S. A., Vasilenko, I. A., Popova, O., & Lifenko, R. A. (2019) · Russian Journal of Human Reproduction · doi:10.17116/repro20192506178 · Cited by 3
Zhang, D., Huang, Y. Q., Peng, C., & Zhou, Y.-F. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i21.4601 · Cited by 4
The role of progestogens in the treatment of endometriosis
Zhylka, N. Y., & Shcherbinska, O. S. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.8.2023.297794 · Cited by 3
The impact of endometriosis on women's mental health and quality of life – review
Nowocin, P., Kudas, Z., Koszyk, M., Litwin, A., Krzywicka, K., Kulczyński, D. W., Dąbrowska, N., Kumięga, P., Perchel, N., & Wasiński, P. (2024) · Medical Science · doi:10.54905/disssi.v28i154.e160ms3483 · Cited by 3
“Women living with the condition frequently express feelings of isolation because family members and friends cannot always appreciate how much they struggle, which serves only to reinforce both their sense of alienation and limits reassuring social support (Caruso et al., 2019).”
Monti, M., Capone, C., Schiavi, M. C., Tucci, C. D., Giannini, A., D’Oria, O., Prata, G., Pinto, A. D., Donato, V. D., Piccioni, M. G., et al. (2020) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2020.101107 · Cited by 2
Washington, K., & Wyatt, H. (2020) · Journal of Feminist Family Therapy · doi:10.1080/08952833.2020.1755169 · Cited by 2
“The vaginal dryness and inflammation that accompany endometriosis and provoked vestibulodynia also is a symptom of autoimmune disorders which can make masturbation or penetrative sex painful (Basson, 2012; Caruso et al., 2019).”
BackgroundChronic pelvic pain in endometriosis: from therapeutic Abstraction to clinical definition: A review
Orazov, M. R., Radzinsky, V. E., & Dolgov, E. D. (2023) · GYNECOLOGY · doi:10.26442/20795696.2023.3.202290 · Cited by 2
Ferreira, F. F., Rosa, V. L. L., Benites, M. N., Cerentini, T. M., de Souza, C. M., Caruso, S., Klahr, P. D. S., da Rosa, L. H. T., Corte, L. D., & da Rosa, P. V. (2020) · Sexual & Relationship Therapy · doi:10.1080/14681994.2020.1817365 · Cited by 2
“The final score ranges from 0 to 100, with 0 corresponding to the worst general health status and 100 corresponding to the best health status (Caruso et al., 2019; Cruz et al., 2013).”
BackgroundSelf-citationEfficacy of dienogest in the treatment of endometrioma‐related pain and subfertility
Ko-Çun, G. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70433 · Cited by 1
Susianto, I. A., Susilaningsih, N., Hidayat, S. T., & Rachmawati, B. (2025) · Gynecology and Minimally Invasive Therapy · doi:10.4103/gmit.gmit-d-24-00021 · Cited by 1
Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability
Hryhorenko, A. M. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.61.72-75 · Cited by 1
To evaluate the effectiveness of dienogest in controlling bleeding abnormalities in endometriosis
Bajaj, S., & Madnani, D. N. (2021) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2021.v5.i4d.994
Sauvanet, É., Lhuillery, D., Loriau, J., Borojeni, S., Dietrich, G., & Angliviel, B. (2020) · Elsevier eBooks · doi:10.1016/b978-2-294-76781-4.00011-9
Psychological Considerations in Endometriosis
Rosa, V. L. L., Commodari, E., & Vitale, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-97236-3_25
Self-citationMedikamentöse Therapie der Endometriose – ein Update
Römer, T. (2022) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-022-00268-6
The use of combined oral contraceptives in patients with endometriosis
Kuznetsova, I. V. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-3-14-20
Medikamentöse Therapie der Endometriose – ein Update
Römer, T. (2023) · Wiener klinisches Magazin · doi:10.1007/s00740-023-00494-z
Endometriosis-Related Complications in Women Undergoing In Vitro Fertilization
Riemma, G., Vitale, S. G., & Angioni, S. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-50662-8_20
Self-citationŠalamun, V., Riemma, G., Klemenc, A., Laganà, A. S., FRANCISCIS, P. D., Štimpfel, M., Korošec, S., & Frangež, H. B. (2024) · Medicina · doi:10.3390/medicina60060959 · Cited by 1
“An ongoing history of dysmenorrhea, which is frequently primary and severe, is a typical early clinical sign of endometriosis [4].”
BackgroundCaruso, S., Cianci, S., Caruso, G., Iraci, M., Gulino, F. A., & Palumbo, M. A. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.113945
Self-citationKumari, P., Ray, R. N., Sarkar, S., Dastidar, S. G., & Munde, Y. (2025) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_113_25
Strong, S. M., Lavington, A., Medina, D., McLaughlin, H., Madhvani, K., & Ball, E. (2025) · doi:10.22541/au.175156697.70025737/v1
Behavioral and Medical Comorbidity: Identifying Challenges and Transforming Systems of Care
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6629-9
Efficacy and acceptability of dienogest among patients with endometriosis in Thailand
Suwan, A., Rungruxsirivorn, T., Panyakhamlerd, K., Apirakviriya, C., Chavaengkiat, S., & Regidor, P. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04287-4
“Dienogest is a 19-nortestosterone derivative and a fourth-generation, orally active progestogen that exhibits highly selective binding to progesterone receptors, while demonstrating negligible binding for estrogen, androgen, glucocorticoid, and mineralocorticoid receptors [13, 14].”
E-sports event and city promotion
Widomski, M. (2023) · Jagiellonian University Repository (Jagiellonian University)
Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103383
Chronic Pelvic Pain: A Clinical Perspective
Graziottin, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_83
The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics
Yan, Y., Lan, X., Mai, H., Tan, H., & Liang, Y. I. X. I. U. (2026) · Biomolecules · doi:10.3390/biom16081080
“Similar results were confirmed in other studies on the impact of dienogest on the quality of life and pain relief of EMS patients [67–69].”
Role of transvaginal color Doppler ultrasound in the diagnosis of pelvic congestion syndrome
Hameed, R. A., & Abbood, A. A. (2026) · International Journal of Research in Medical Science · doi:10.33545/26648733.2026.v8.i9a.255
Chernyak, M. M. (2026) · Theoretical and Practical Aspects of Modern Scientific Research · doi:10.36074/logos-14.08.2026.019
Metadata
- Authors
- Caruso, S., Iraci, M., Cianci, S., Vitale, S. G., Fava, V., & Cianci, A.
- Affiliations
- University of Catania (IT)
- Corresponding author
- Vitale, Salvatore Giovanni
- ORCID
- Venue
- Journal of Pain Research
- Publisher
- Informa UK Limited
- Published
- 2019-07
- Volume
- Volume 12
- Pages
- 2371-2378
- ISSN
- 1178-7090 (ISSN-L)
- PMC
- PMC6681157
- OpenAlex
- W2965687471
- Cited by
- 73
- References
- 37
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 9 · 2021: 18 · 2020: 14 · 2019: 1
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Pain Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Università di Catania
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- dienogest, endometriosis, chronic pelvic pain, dysmenorrhea, dyspareunia, quality of life, sexual function, sexual distress, long-term treatment, nonsteroidal anti-inflammatory drugs, progestogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.